These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20829525)

  • 1. Re: Predictive value of symptoms for early detection of ovarian cancer.
    Jordan SJ; Coory MD; Webb PM;
    J Natl Cancer Inst; 2010 Oct; 102(20):1599-601; author reply 1601. PubMed ID: 20829525
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Predictive value of symptoms for early detection of ovarian cancer.
    Valdes R; Del Priore G
    J Natl Cancer Inst; 2010 Oct; 102(20):1599; author reply 1601. PubMed ID: 20829526
    [No Abstract]   [Full Text] [Related]  

  • 3. Ovarian cancer symptoms speak out--but what are they really saying?
    Cass I; Karlan BY
    J Natl Cancer Inst; 2010 Feb; 102(4):211-2. PubMed ID: 20110550
    [No Abstract]   [Full Text] [Related]  

  • 4. Personalizing ovarian cancer screening.
    Goozner M
    J Natl Cancer Inst; 2010 Aug; 102(15):1112-3. PubMed ID: 20668268
    [No Abstract]   [Full Text] [Related]  

  • 5. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
    Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ
    J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A step forward for two-step screening for ovarian cancer.
    Hensley ML
    J Clin Oncol; 2010 May; 28(13):2128-30. PubMed ID: 20368556
    [No Abstract]   [Full Text] [Related]  

  • 7. Women's awareness of ovarian cancer risks and symptoms.
    Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW
    Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of serum biomarkers for detection of early-stage ovarian cancer.
    Nosov V; Su F; Amneus M; Birrer M; Robins T; Kotlerman J; Reddy S; Farias-Eisner R
    Am J Obstet Gynecol; 2009 Jun; 200(6):639.e1-5. PubMed ID: 19285648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early symptoms of ovarian cancer: a case-control study without recall bias.
    Friedman GD; Skilling JS; Udaltsova NV; Smith LH
    Fam Pract; 2005 Oct; 22(5):548-53. PubMed ID: 15964871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy.
    Fagotti A; Fanfani F; Rossitto C; Lorusso D; De Gaetano AM; Giordano A; Vizzielli G; Scambia G
    Oncology; 2008; 75(3-4):152-8. PubMed ID: 18827492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation on non invasive diagnostic tests for the second look in epithelial ovarian cancer].
    García Enguídanos A; Crespo Azanza E; Díaz Recaséns J; Lobo Samper F; Jorge Herrero JA; Sáinz de la Cuesta Abbad R
    Rev Clin Esp; 1998 Aug; 198(8):502-5. PubMed ID: 9774878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
    Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms are not early signs of ovarian cancer.
    Mourits MJ; de Bock GH
    BMJ; 2009 Sep; 339():b3955. PubMed ID: 19808814
    [No Abstract]   [Full Text] [Related]  

  • 14. Ovarian cancer: predictors of early-stage diagnosis.
    Morris CR; Sands MT; Smith LH
    Cancer Causes Control; 2010 Aug; 21(8):1203-11. PubMed ID: 20364367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer. Usefulness of abdominal symptoms in early diagnosis.
    Wheatley G
    BMJ; 2009 Sep; 339():b3954. PubMed ID: 19808813
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer.
    Hermsen BB; von Mensdorff-Pouilly S; Berkhof J; van Diest PJ; Gille JJ; Menko FH; Blankenstein MA; Kenemans P; Verheijen RH
    J Clin Oncol; 2007 Apr; 25(11):1383-9. PubMed ID: 17416858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early detection and preoperative diagnosis of ovarian carcinoma].
    Kainz C
    Wien Med Wochenschr; 1996; 146(1-2):2-7. PubMed ID: 8835487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and detection of ovarian cancer.
    Breedlove G; Busenhart C
    J Midwifery Womens Health; 2005; 50(1):51-4. PubMed ID: 15637515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The leukocyte adherence inhibition test (LAI) in preoperative diagnosis of epithelial ovarian cancer.
    Dgani R; Shani A; Elchalal U; Harpaz N; Bentwich Z; Fink A
    Gynecol Oncol; 1993 Jun; 49(3):349-53. PubMed ID: 8314537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for the early detection of cancer: an inflammatory concept.
    Roy HK; Khandekar JD
    Arch Intern Med; 2007 Sep; 167(17):1822-4. PubMed ID: 17893302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.